BOSTON BIOTECH
Dead / Abandoned — Abandoned — no statement of use filed (as of 30 Mar 2026)
What this means for you
This application is over — abandoned 30 Mar 2026. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 98323700
- Mark type
- Design + words
- Filed
- 20 Dec 2023
- Published for opposition
- 02 Jul 2024
- Abandoned
- 30 Mar 2026
- Attorney of record
- Camille M. Miller
Goods and services
- Class 042 — Scientific and technological services: Research and development in the pharmaceutical and biotechnology fields; pharmaceutical drug development services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Owner
- Boston Pharmaceuticals, Inc., Cambridge, MA, US
- Boston Pharmaceuticals, Inc., Cambridge, MA, US
Prosecution history
- 30 Mar 2026 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 30 Mar 2026 — ABANDONMENT - NO USE STATEMENT FILED
- 18 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Jul 2025 — SOU EXTENSION 2 GRANTED
- 17 Jul 2025 — SOU EXTENSION 2 FILED
- 17 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 28 Aug 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Aug 2024 — SOU EXTENSION 1 GRANTED
- 28 Aug 2024 — SOU EXTENSION 1 FILED
- 28 Aug 2024 — SOU TEAS EXTENSION RECEIVED
- 27 Aug 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 02 Jul 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 02 Jul 2024 — PUBLISHED FOR OPPOSITION
- 12 Jun 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 25 May 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER